These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37859328)

  • 1. Understanding Alzheimer's Disease and its Metal Chelation Therapeutics: A Narrative Review.
    Thakur R; Karwasra R; Umar T
    Curr Pharm Des; 2023; 29(30):2377-2386. PubMed ID: 37859328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
    Domingo JL
    J Alzheimers Dis; 2006 Nov; 10(2-3):331-41. PubMed ID: 17119296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of metals as therapeutic targets in Alzheimer's disease.
    Finefrock AE; Bush AI; Doraiswamy PM
    J Am Geriatr Soc; 2003 Aug; 51(8):1143-8. PubMed ID: 12890080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
    Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
    J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal chelator decreases Alzheimer beta-amyloid plaques.
    Gouras GK; Beal MF
    Neuron; 2001 Jun; 30(3):641-2. PubMed ID: 11430794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
    Mancino AM; Hindo SS; Kochi A; Lim MH
    Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes.
    Di Vaira M; Bazzicalupi C; Orioli P; Messori L; Bruni B; Zatta P
    Inorg Chem; 2004 Jun; 43(13):3795-7. PubMed ID: 15206857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease.
    Singh SK; Balendra V; Obaid AA; Esposto J; Tikhonova MA; Gautam NK; Poeggeler B
    Metallomics; 2022 Jun; 14(6):. PubMed ID: 35333348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease, metal ions and metal homeostatic therapy.
    Zatta P; Drago D; Bolognin S; Sensi SL
    Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.
    Chaudhari V; Bagwe-Parab S; Buttar HS; Gupta S; Vora A; Kaur G
    Neurotox Res; 2023 Jun; 41(3):270-287. PubMed ID: 36705861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Alzheimer's disease with clioquinol.
    Regland B; Lehmann W; Abedini I; Blennow K; Jonsson M; Karlsson I; Sjögren M; Wallin A; Xilinas M; Gottfries CG
    Dement Geriatr Cogn Disord; 2001; 12(6):408-14. PubMed ID: 11598313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. '...and C is for Clioquinol' - the AbetaCs of Alzheimer's disease.
    Melov S
    Trends Neurosci; 2002 Mar; 25(3):121-3; discussion 123-4. PubMed ID: 11852134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of metals in Alzheimer's disease.
    Das N; Raymick J; Sarkar S
    Metab Brain Dis; 2021 Oct; 36(7):1627-1639. PubMed ID: 34313926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
    Lakey-Beitia J; Burillo AM; La Penna G; Hegde ML; Rao KS
    J Alzheimers Dis; 2021; 82(s1):S335-S357. PubMed ID: 32568200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
    Crouch PJ; Barnham KJ; Bush AI; White AR
    Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's disease.
    Treiber C; Simons A; Strauss M; Hafner M; Cappai R; Bayer TA; Multhaup G
    J Biol Chem; 2004 Dec; 279(50):51958-64. PubMed ID: 15465814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal protein attenuating compounds for the treatment of Alzheimer's dementia.
    Sampson EL; Jenagaratnam L; McShane R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005380. PubMed ID: 24563468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal complexing agents as therapies for Alzheimer's disease.
    Bush AI
    Neurobiol Aging; 2002; 23(6):1031-8. PubMed ID: 12470799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-beta metal interaction and metal chelation.
    Cuajungco MP; Frederickson CJ; Bush AI
    Subcell Biochem; 2005; 38():235-54. PubMed ID: 15709482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.